{"url_path":"/sec/tgtx/8-k/2026-03-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-20","source_url":"https://www.sec.gov/Archives/edgar/data/1001316/0001437749-26-009253-index.html","accession_number":"0001437749-26-009253","cik":"0001001316","ticker":"TGTX","issuer_name":"TG THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1001316/0001437749-26-009253-index.html","primary_entity_key":"0001001316","primary_entity_name":"TG THERAPEUTICS, INC."},"word_count":76,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\n**Exhibit No.**\n\n \n \n\n**Description**\n\n104\n\n \n \n\nThe cover page from this Current Report on Form 8-K formatted in Inline XBRL.\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nTG Therapeutics, Inc.\n\n \n\n(Registrant)\n\n \n \n \n\nDate: March 20, 2026\n\nBy:\n\n/s/ Sean A. Power\n\n \n \n\n Sean A. Power\n\n \n \n\n Chief Financial Officer"}